Hepatobiliary Surgery Practice Questions

Q: According to the Bismuth-Corlette classification system, perihilar cholangiocarcinomas extending into the right secondary intrahepatic ducts are classified as what type?

Type IIIa. ### Explanation The **Bismuth-Corlette classification** is the standard system used to categorize perihilar cholangiocarcinomas (Klatskin tumors) based on the anatomical extent of biliary involvement. This classification is crucial for determining surgical resectability. **Why Type IIIa is Correct:** * **Type IIIa** tumors involve the confluence of the hepatic ducts and extend specifically into the **right secondary intrahepatic ducts** (right hepatic duct and its branches). * In contrast, **Type IIIb** involves the confluence and extends into the **left secondary intrahepatic ducts**. **Analysis of Incorrect Options:** * **Type II (Option A):** The tumor is limited to the confluence of the right and left hepatic ducts but does not extend into the secondary intrahepatic branches. * **Type IIIb (Option B):** As noted above, this involves the left-sided secondary ducts. A helpful mnemonic: **"a"** for **A**way from the heart (Right), **"b"** for **B**ack toward the heart (Left). * **Type IV (Option D):** This represents extensive disease involving the confluence and **both** right and left secondary intrahepatic ducts, or a multicentric distribution. **High-Yield Clinical Pearls for NEET-PG:** * **Type I:** Tumor involves the common hepatic duct distal to the confluence. * **Surgical Management:** Types I, II, and III are generally considered potentially resectable (Type IIIa requires a right hemihepatectomy; Type IIIb requires a left hemihepatectomy). Type IV is often considered unresectable. * **Imaging:** MRCP (Magnetic Resonance Cholangiopancreatography) is the gold standard for non-invasive mapping of the biliary tree in these patients. * **Clinical Presentation:** Patients typically present with painless, progressive obstructive jaundice and a palpable gallbladder (Courvoisier’s Law) is usually absent because the obstruction is proximal to the cystic duct.

Q: A male patient undergoes laparoscopic cholecystectomy, and the specimen is sent for histopathology, which shows carcinoma of the gallbladder, stage T1a. What is the appropriate management?

Excision of all port sites.. **Explanation:** The management of incidental gallbladder cancer (GBC) found after laparoscopic cholecystectomy depends strictly on the **T-stage** (depth of invasion). **Why Option C is Correct:** In the context of laparoscopic cholecystectomy for GBC, there is a high risk of **port-site metastasis** due to bile spillage or instrumentation. For a **T1a tumor** (invasion limited to the lamina propria), a simple cholecystectomy is oncologically sufficient as the risk of lymph node metastasis is <1%. However, if the surgery was performed laparoscopically and GBC was diagnosed postoperatively, the standard surgical protocol to prevent recurrence includes the **excision of all port sites**. **Why other options are incorrect:** * **Option A:** Simple follow-up is insufficient because the port sites remain a potential nidus for seeding. * **Option B:** Extended cholecystectomy (wedge resection of the liver bed + lymphadenectomy) is the treatment of choice for **T1b tumors** (invasion of the muscular layer) and above. It is considered "over-treatment" for T1a. * **Option D:** Radiotherapy is not the primary management for early-stage (T1a) GBC; it is reserved for advanced or palliative cases. **High-Yield Clinical Pearls for NEET-PG:** * **T1a:** Simple Cholecystectomy is enough (if done open). If laparoscopic, port site excision is indicated. * **T1b, T2, T3:** Require **Extended/Radical Cholecystectomy** (includes 2-3 cm liver wedge resection and cystic/pericholedochal lymph node dissection). * **Most common site of GBC:** Fundus. * **Most common histological type:** Adenocarcinoma. * **Nevin’s Staging** and **AJCC Staging** are both used, but AJCC (TNM) is the current gold standard for management decisions.

Q: An elderly man presents with a history of jaundice and pain abdomen. What is the investigation of choice?

Ultrasound. **Explanation:** In any patient presenting with jaundice and abdominal pain, the primary clinical objective is to differentiate between **medical jaundice** (hepatocellular) and **surgical jaundice** (obstructive). **1. Why Ultrasound (USG) is the Investigation of Choice:** Ultrasound is the **initial and best screening investigation** for jaundice. It is highly sensitive in detecting **biliary tree dilatation**, which confirms an obstructive etiology. It can effectively identify gallstones, choledocholithiasis (CBD stones), and mass lesions in the head of the pancreas. Its advantages include being non-invasive, radiation-free, cost-effective, and widely available. **2. Why other options are incorrect:** * **CT Scan:** While a Contrast-Enhanced CT (CECT) is the investigation of choice for **staging** pancreatic or periampullary tumors, it is not the first-line screening tool. It is usually performed *after* an ultrasound suggests a mass or if the USG is inconclusive. * **4-quadrant aspiration (DPL):** This is used in trauma settings to detect hemoperitoneum. It has no role in the diagnostic workup of jaundice. * **X-ray Abdomen:** This has very low sensitivity for jaundice. Only about 10-15% of gallstones are radio-opaque, making it an unreliable tool for biliary pathology. **Clinical Pearls for NEET-PG:** * **First investigation for Jaundice:** Ultrasound. * **Gold Standard for CBD stones:** MRCP (Non-invasive) or ERCP (Invasive/Therapeutic). * **Investigation of choice for Pancreatic Carcinoma:** Triphasic CT scan. * **Courvoisier’s Law:** In a patient with obstructive jaundice, if the gallbladder is palpable, the obstruction is likely due to a malignancy (e.g., periampullary carcinoma) rather than stones, as stones cause a fibrosed, non-distensible gallbladder.

Q: A 40-year-old patient presents to the emergency department with abdominal colic and features of obstructive jaundice. Her counts and liver enzymes were elevated. A USG revealed a scleroatrophic gallbladder, CBD impacted with stones, and intrahepatic biliary radicle (IHBR) dilation. What is the next step in the management of this patient?

ERCP-MRCP. **Explanation:** The patient presents with the classic triad of **obstructive jaundice** (elevated enzymes, IHBR dilation), **biliary colic**, and signs of **cholangitis** (elevated counts). The ultrasound confirms the presence of **Choledocholithiasis** (CBD stones). **Why ERCP-MRCP is the correct answer:** In cases of suspected CBD stones with features of biliary obstruction or infection, the priority is to **decompress the biliary tree**. * **ERCP (Endoscopic Retrograde Cholangiopancreatography)** is the gold standard for management because it is both diagnostic and therapeutic. It allows for sphincterotomy and stone extraction, addressing the immediate life-threatening obstruction. * **MRCP** is a non-invasive diagnostic tool used to map the biliary anatomy if the diagnosis is in doubt, but in this clinical scenario (impacted stones seen on USG), ERCP is the definitive next step for intervention. **Why other options are incorrect:** * **Cholecystectomy:** While the patient has a scleroatrophic gallbladder that will eventually need removal, performing a cholecystectomy *before* clearing the CBD is contraindicated. Removing the gallbladder does not solve the CBD obstruction and increases the risk of post-operative complications. * **CT Scan:** While CT can show biliary dilation, it is less sensitive than USG for gallstones and lacks the therapeutic capability of ERCP. It would delay definitive treatment. **Clinical Pearls for NEET-PG:** * **Management Sequence:** For Choledocholithiasis, the standard sequence is **ERCP (to clear CBD) followed by Laparoscopic Cholecystectomy** (usually within 72 hours). * **Charcot’s Triad:** Fever, Jaundice, and RUQ pain (indicative of Cholangitis). * **Scleroatrophic Gallbladder:** Often associated with chronic cholecystitis and increases the risk of Mirizzi Syndrome or Gallbladder Carcinoma.

Q: Bleeding in a case of obstructive jaundice is treated with which of the following?

Fresh frozen plasma. **Explanation:** In obstructive jaundice, the absence of bile salts in the duodenum leads to the malabsorption of fat-soluble vitamins (A, D, E, and **K**). Vitamin K is a critical cofactor for the γ-carboxylation of **Clotting Factors II, VII, IX, and X**. A deficiency in these factors results in a prolonged Prothrombin Time (PT) and an increased risk of bleeding. **Why Fresh Frozen Plasma (FFP) is the correct choice:** When a patient with obstructive jaundice is actively bleeding or requires emergency surgery, the immediate goal is to replace the deficient clotting factors. **FFP** contains all the coagulation factors in physiological concentrations. While Vitamin K injection is the treatment for chronic correction, it takes 12–24 hours to synthesize new factors. In an acute bleeding scenario, FFP provides an immediate source of functional factors II, VII, IX, and X. **Analysis of Incorrect Options:** * **Cryoprecipitate:** Contains primarily Factor VIII, Fibrinogen, von Willebrand factor, and Factor XIII. It lacks the Vitamin K-dependent factors (II, VII, IX, X) needed here. * **Whole Blood:** While it contains factors, it is not the concentrated source of choice and carries a higher risk of volume overload and transfusion reactions. * **Buffy Coat Extract:** This is a source of leukocytes and platelets, not coagulation factors. **Clinical Pearls for NEET-PG:** * **Initial Investigation:** PT/INR is the most sensitive indicator of liver synthetic function and Vitamin K deficiency. * **Diagnostic Test:** The **Kovler Test** (parenteral Vitamin K administration) helps differentiate between obstructive jaundice (PT improves) and hepatocellular jaundice (PT does not improve). * **Pre-operative Prep:** Always administer Vitamin K (10mg IV/SC) for 3 days prior to surgery in obstructive jaundice patients to prevent "Biliary Hemorrhage."

Q: What is the most appropriate investigation for the diagnosis of common bile duct stones?

ERCP (Endoscopic Retrograde Cholangiopancreatography). **Explanation:** The diagnosis and management of Common Bile Duct (CBD) stones (choledocholithiasis) require high sensitivity and, ideally, therapeutic capability. **Why ERCP is the Correct Answer:** Endoscopic Retrograde Cholangiopancreatography (ERCP) is traditionally considered the **Gold Standard** for the diagnosis of CBD stones. Its primary advantage is that it is both **diagnostic and therapeutic**. Once stones are identified via fluoroscopy with contrast injection, they can be immediately removed via sphincterotomy and stone extraction (using balloons or baskets). While MRCP is now the preferred non-invasive diagnostic tool, ERCP remains the definitive "investigation of choice" in clinical scenarios where intervention is anticipated. **Analysis of Incorrect Options:** * **Ultrasonography (USG):** This is the **initial/screening investigation** for biliary disease. While excellent for detecting gallstones (cholelithiasis) and CBD dilation, it has low sensitivity (approx. 20-50%) for directly visualizing stones in the distal CBD due to interference from overlying bowel gas. * **Oral Cholecystography:** This historical method involves oral contrast to visualize the gallbladder. It is obsolete and cannot reliably visualize the CBD or detect choledocholithiasis. * **Intravenous Cholangiography:** This involves IV contrast excreted into the bile. It has been replaced by safer, more accurate modalities like MRCP and ERCP due to high toxicity and poor opacification in jaundiced patients. **High-Yield Clinical Pearls for NEET-PG:** * **Best Initial Investigation:** USG Abdomen. * **Best Non-Invasive Investigation (Gold Standard for Diagnosis):** MRCP (Magnetic Resonance Cholangiopancreatography). * **Gold Standard (Diagnostic + Therapeutic):** ERCP. * **IOC for Gallstones (Cholelithiasis):** USG. * **Most sensitive per-operative method:** Intraoperative Ultrasound or Cholangiography.

Q: Which of the following is NOT true regarding Caroli's disease?

Caroli's disease commonly presents with ascites.. **Explanation:** Caroli’s disease is a rare congenital disorder characterized by **non-obstructive, saccular, or fusiform dilatation of the intrahepatic bile ducts**. It is classified as a **Todani Type V** choledochal cyst. **Why Option C is the correct answer (False statement):** Caroli’s disease primarily affects the biliary tree, not the hepatic parenchyma or portal venous system. Therefore, it does not typically cause portal hypertension or liver failure in its pure form. **Ascites** is a feature of portal hypertension; its absence is a hallmark of pure Caroli’s disease. If portal hypertension and ascites are present, the condition is referred to as **Caroli’s Syndrome**, which is the association of Caroli’s disease with congenital hepatic fibrosis. **Analysis of other options:** * **Option A:** Stasis of bile within the dilated intrahepatic ducts leads to stone formation (hepatolithiasis) and recurrent bouts of **bacterial cholangitis**, which is the most common presentation. * **Option B:** While "Caroli’s Disease" refers to isolated ductal dilatation, it is frequently associated with **congenital hepatic fibrosis** and autosomal recessive polycystic kidney disease (ARPKD); this combination is known as **Caroli’s Syndrome**. * **Option D:** Chronic inflammation and bile stasis predispose patients to malignancy. There is a 7-15% lifetime risk of developing **cholangiocarcinoma**. **High-Yield Pearls for NEET-PG:** * **Inheritance:** Usually Autosomal Recessive. * **Imaging Gold Standard:** MRCP (shows "Central Dot Sign" on CT—representing portal vein branches surrounded by dilated bile ducts). * **Treatment:** Localized disease is treated with lobectomy; diffuse disease may require liver transplantation.

Q: Which of the following statements regarding fibrolamellar carcinoma of the liver is FALSE, except?

Common in 20-30 year olds. **Explanation:** Fibrolamellar Carcinoma (FLC) is a distinct variant of Hepatocellular Carcinoma (HCC) that typically occurs in young adults without underlying liver disease. **Why Option A is Correct:** The question asks for the statement that is **NOT false** (i.e., the true statement). FLC characteristically affects young patients, typically between the ages of **20 and 30 years**, with an equal distribution between males and females. Unlike conventional HCC, it is not associated with chronic viral hepatitis or metabolic liver diseases. **Analysis of Incorrect Options:** * **Option B (Associated with cirrhosis):** This is **False**. FLC typically arises in a **non-cirrhotic liver**. This is a key diagnostic differentiator from conventional HCC. * **Option C (Prognosis is poor):** This is **False**. FLC generally has a **better prognosis** than conventional HCC because the patients are younger, the surrounding liver is healthy (allowing for more aggressive surgical resection), and the tumor is often slow-growing. * **Option D (AFP positive in 95%):** This is **False**. Serum **Alpha-fetoprotein (AFP) levels are usually normal** in FLC. Instead, neurotensin levels or Vitamin B12 binding capacity may be elevated. **NEET-PG High-Yield Pearls:** * **Histology:** Characterized by large polygonal cells with eosinophilic cytoplasm and prominent nucleoli, separated by **parallel lamellae of collagen fibers** (hence the name). * **Imaging:** Often presents as a large, well-circumscribed mass with a **central stellate scar** (similar to Focal Nodular Hyperplasia, but the scar in FLC is typically calcified and does not enhance on delayed imaging). * **Treatment:** Surgical resection (lobectomy) is the treatment of choice and offers a high cure rate.

Q: A patient has 50ml of bile output from an abdominal drain on the first postoperative day. What is the appropriate management?

Observation. **Explanation:** **1. Why Observation is Correct:** The management of postoperative bile leak depends primarily on the **volume of the leak** and the **clinical stability** of the patient. A bile output of **50 ml/day** is considered a low-volume leak (typically defined as <300–400 ml/day). On the first postoperative day, minor leaks often occur from the gallbladder bed (Luschka’s ducts) or minor accessory ducts. Most of these low-volume leaks are self-limiting and resolve spontaneously as the inflammatory process subsides, provided the patient is hemodynamically stable and there are no signs of peritonitis. **2. Why Other Options are Incorrect:** * **Immediate Exploration (B):** This is indicated only if the patient shows signs of generalized peritonitis, hemodynamic instability, or a major biliary enteric disruption. Early re-operation in an inflamed field increases the risk of further ductal injury. * **Intrabiliary Stenting (ERCP) (A):** While ERCP with stenting is the gold standard for persistent or high-volume leaks (to decrease the pressure gradient), it is not the first step for a minor 50ml leak on Day 1. It is reserved for cases where drainage does not decrease over 4–7 days. * **T-tube Drainage (C):** This is a surgical procedure used during the primary operation (like CBD exploration) or during a formal repair; it is not a bedside management option for a minor drain leak. **Clinical Pearls for NEET-PG:** * **Low-volume leak:** 400–500 ml/day; likely indicates a major ductal injury or cystic duct stump leak; requires ERCP/Stenting. * **Most common site of leak post-cholecystectomy:** Cystic duct stump. * **Strasberg Classification:** Used to grade bile duct injuries (Type A is most common: leak from cystic duct or Luschka duct).

Q: What is the best treatment modality for a common bile duct stone?

Endoscopic sphincterotomy. **Explanation:** The management of common bile duct (CBD) stones (choledocholithiasis) focuses on clearing the duct to prevent complications like obstructive jaundice, cholangitis, and gallstone pancreatitis. **Why Endoscopic Sphincterotomy is Correct:** Endoscopic Retrograde Cholangiopancreatography (ERCP) with **Endoscopic Sphincterotomy (ES)** followed by stone extraction (using baskets or balloons) is currently the **gold standard** and treatment of choice. It is minimally invasive, highly effective (success rate >90%), and allows for immediate decompression of the biliary tree. In patients with an intact gallbladder, ERCP is typically followed by elective laparoscopic cholecystectomy. **Analysis of Incorrect Options:** * **Observation:** CBD stones rarely pass spontaneously and carry a high risk of life-threatening complications (ascending cholangitis). Therefore, "wait and watch" is never recommended. * **Chenodeoxycholic acid:** This bile acid is used for the medical dissolution of small, radiolucent *gallbladder* stones in symptomatic patients who are unfit for surgery. It is ineffective for CBD stones and takes months to work. * **Percutaneous removal:** Percutaneous Transhepatic Biliary Drainage (PTBD) is a second-line intervention. It is reserved for cases where ERCP fails or is anatomically impossible (e.g., previous Roux-en-Y gastric bypass). **Clinical Pearls for NEET-PG:** * **Most common type of CBD stone:** Secondary stones (migrated from the gallbladder). * **Investigation of choice (Initial):** Ultrasound (shows dilated CBD). * **Investigation of choice (Gold Standard/Diagnostic):** MRCP (non-invasive) or ERCP (invasive/therapeutic). * **Charcot’s Triad:** Fever, jaundice, and RUQ pain—indicates urgent need for CBD decompression.

Question 1

According to the Bismuth-Corlette classification system, perihilar cholangiocarcinomas extending into the right secondary intrahepatic ducts are classified as what type?

Accepted Answer

Type IIIa

Answer

Type II

Answer

Type IIIb

Answer

Type IV

Question 2

A male patient undergoes laparoscopic cholecystectomy, and the specimen is sent for histopathology, which shows carcinoma of the gallbladder, stage T1a. What is the appropriate management?

Accepted Answer

Excision of all port sites.

Answer

Conservative management and follow-up.

Answer

Extended cholecystectomy.

Answer

Radiotherapy.

Question 3

An elderly man presents with a history of jaundice and pain abdomen. What is the investigation of choice?

Accepted Answer

Ultrasound

Answer

4-quadrant aspiration

Answer

CT scan

Answer

X-ray abdomen

Question 4

A 40-year-old patient presents to the emergency department with abdominal colic and features of obstructive jaundice. Her counts and liver enzymes were elevated. A USG revealed a scleroatrophic gallbladder, CBD impacted with stones, and intrahepatic biliary radicle (IHBR) dilation. What is the next step in the management of this patient?

Accepted Answer

ERCP-MRCP

Answer

Cholecystectomy

Answer

CT scan

Answer

None of the above

Question 5

Bleeding in a case of obstructive jaundice is treated with which of the following?

Accepted Answer

Fresh frozen plasma

Answer

Cryoprecipitate

Answer

Whole blood

Answer

Buffy coat extract

Question 6

What is the most appropriate investigation for the diagnosis of common bile duct stones?

Accepted Answer

ERCP (Endoscopic Retrograde Cholangiopancreatography)

Answer

Ultrasonography

Answer

Oral Cholecystography

Answer

Intravenous Cholangiography

Question 7

Which of the following is NOT true regarding Caroli's disease?

Accepted Answer

Caroli's disease commonly presents with ascites.

Answer

Cholangitis is associated with Caroli's disease.

Answer

Caroli's disease is associated with congenital hepatic fibrosis.

Answer

Malignant change can occur in Caroli's disease.

Question 8

Which of the following statements regarding fibrolamellar carcinoma of the liver is FALSE, except?

Accepted Answer

Common in 20-30 year olds

Answer

Commonly associated with cirrhosis

Answer

Prognosis is poor

Answer

Alpha-fetoprotein is positive in 95% of cases

Question 9

A patient has 50ml of bile output from an abdominal drain on the first postoperative day. What is the appropriate management?

Accepted Answer

Observation

Answer

Intrabiliary stent

Answer

Immediate exploration

Answer

T-tube drainage

Question 10

What is the best treatment modality for a common bile duct stone?

Accepted Answer

Endoscopic sphincterotomy

Answer

Observation

Answer

Chenodeoxycholic acid

Answer

Percutaneous removal

Hepatobiliary Surgery — MCQs

Hepatobiliary Surgery — MCQs

On this page

Practice by Chapter

Want unlimited practice?